There have been technological advancements in four principal areas of heart care, most notably, medications, medical technologies, heart-supporting devices, and regenerative heart therapies. New medication options have emerged in recent years, which can help stabilize chest pain, lower the risk of death and hospitalization, and assist obese patients with heart conditions.

For digital health technologies, there are implantable devices, and phone apps, which can help doctors monitor patients’ cardiovascular health and enhance their results. The Bionic Pacemaker is a modern technology that creates a natural variation in the heartbeat, improving overall energy and the heart's ability to pump blood throughout the body. Mechanical Hearts is another technology that has shown promise in regenerative heart therapy development, where mechanical heart technology can generate new muscle tissue for patients with heart failure.

Overall, these advancements offer hope for the future of cardiac care and can help reduce the risk of cardiovascular disease. Technological advancements in heart surgery have increased the capacity to treat patients with intricate cardiac and coronary anatomy. Using innovative devices and advanced imaging techniques has revolutionized the management of complex coronary anatomy and valvular diseases. Bioabsorbable vascular scaffolds have emerged as a breakthrough in coronary stenting, while advanced 3D imaging facilitates precise diagnosis and treatment of complex coronary and structural issues.

The management of structural heart disease has been transformed by transcatheter interventional procedures such as TAVR, TPVR, TMVR, and tricuspid valve coaptation devices. Additionally, decellularized hearts can serve as scaffolds of native extracellular matrix, offering a perfect platform for rebuilding functional cardiac tissue.

The drug-eluting balloon is a recent innovative advancement in cardiology that has revolutionized cardiovascular medicine. This innovative device allows for safe angioplasty without the need for stents. It combines the advantages of angioplasty and drug delivery, providing a unique approach to treating narrowed or blocked arteries, as well as blockages in previously inserted stents. Unlike traditional angioplasty which only mechanically opens the vessel, the drug-eluting balloon releases medication directly into the affected area, preventing the artery from re-narrowing or experiencing restenosis. This breakthrough technology reduces the necessity for stents and can enhance long-term patient outcomes.

It is vital to emphasize the significance of screening, early diagnosis, and timely intervention in congenital heart disease (CHD), which significantly enhances the chances of a baby's survival into adulthood. With advancements in pediatric cardiology and cardiac surgery, it is now possible to repair or alleviate most CHDs, including complex ones. Given that twelve out of every one thousand newborns have congenital heart disease, prompt treatment can help ensure a normal and productive life.

EMA supplies Almana Hospital's Cardiology and Vascular Unit with a comprehensive range of solutions for detecting, diagnosing, and treating various heart and cardiovascular conditions, including Atrial Fibrillation, Heart Failure, Transplant, and Cardiac Valve Disease, among others. We have implemented noninvasive tests such as cardiac MRI to aid the diagnosis process. 

Additionally, we have introduced new imaging tools like cardiac PET, a nuclear imaging technique that utilizes minimal doses of radioactivity. This has enabled doctors to obtain a detailed view of patients' hearts and facilitated a better understanding and personalized care for each case. We are committed to continuously upgrading our warehouses with the latest technologies to ensure medicine availability for those in need. EMA is committed to bringing the latest heart care technologies to the Kingdom and empowering healthcare professionals with the latest advancements in cardiology to improve patient results. 

BACK TO NEWS PAGE